WCA
GILD icon

Westover Capital Advisors’s Gilead Sciences GILD Stock Holding History

Westover Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
15,885
-387
-2% -$51K 0.33% 62
2026
Q1 		$2.27M Buy
16,272
+1,293
+9% +$181K 0.42% 57
2025
Q4 		$1.84M Sell
14,979
-325
-2% -$39.5K 0.33% 63
2025
Q3 		$1.7M Buy
15,304
+218
+1% +$24.8K 0.31% 65
2025
Q2 		$1.67M Buy
15,086
+8,199
+119% +$873K 0.33% 65
2025
Q1 		$772K Buy
+6,887
New +$711K 0.17% 110
2024
Q1 		– Sell
-3,779
Closed -$306K – 195
2023
Q4 		$306K Buy
3,779
+19
+0.5% +$1.48K 0.1% 139
2023
Q3 		$282K Hold
3,760
– – 0.1% 141
2023
Q2 		$290K Buy
+3,760
New +$300K 0.1% 145
2020
Q4 		– Sell
-7,699
Closed -$486K – 155
2020
Q3 		$486K Sell
7,699
-1,740
-18% -$121K 0.2% 89
2020
Q2 		$726K Buy
9,439
+6,066
+180% +$465K 0.34% 73
2020
Q1 		$252K Buy
+3,373
New +$233K 0.14% 99
2017
Q2 		– Sell
-5,563
Closed -$378K – 113
2017
Q1 		$378K Buy
5,563
+46
+0.8% +$3.23K 0.25% 81
2016
Q4 		$395K Sell
5,517
-7,968
-59% -$592K 0.28% 75
2016
Q3 		$1.07M Sell
13,485
-1,484
-10% -$121K 0.79% 42
2016
Q2 		$1.25M Buy
14,969
+2,314
+18% +$205K 1.02% 36
2016
Q1 		$1.16M Buy
12,655
+1,699
+16% +$153K 0.98% 36
2015
Q4 		$1.11M Buy
10,956
+1,327
+14% +$138K 0.92% 39
2015
Q3 		$945K Sell
9,629
-17
-0.2% -$1.89K 0.81% 41
2015
Q2 		$1.13M Buy
9,646
+1,155
+14% +$126K 0.9% 38
2015
Q1 		$833K Buy
+8,491
New +$862K 0.67% 49
2014
Q4 		– Sell
-1,954
Closed -$208K – 87
2014
Q3 		$208K Buy
+1,954
New +$191K 0.17% 87

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Westover Capital Advisors's GILD Position: Q2 2026 in Review

Westover Capital Advisors reduced its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, selling an estimated $51K and leaving 15,885 shares worth $2.01M. The position accounts for 0.33% of the portfolio, ranked #62.

Westover Capital Advisors first reported a position in GILD in Q3 2014 and has held it in 22 quarters since. The position peaked at $2.27M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Westover Capital Advisors held 15,885 shares of Gilead Sciences worth $2.01M as of Q2 2026.
  • Westover Capital Advisors sold 387 Gilead Sciences shares in Q2 2026, an estimated $51K.
  • Gilead Sciences made up 0.33% of Westover Capital Advisors's portfolio in Q2 2026, its #62 holding.
  • Westover Capital Advisors first reported a position in Gilead Sciences in Q3 2014 and has held it in 22 quarters since.
  • Westover Capital Advisors's Gilead Sciences position peaked at $2.27M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Westover Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.